Barrington Research Reiterates Outperform on HealthEquity, Raises Price Target to $85
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst Alexander Paris has reiterated an 'Outperform' rating on HealthEquity (NASDAQ:HQY) and raised the price target from $80 to $85.
September 06, 2023 | 3:27 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HealthEquity's stock rating has been reiterated as 'Outperform' by Barrington Research, with a raised price target from $80 to $85.
The reiteration of the 'Outperform' rating and the increase in price target by Barrington Research indicates a positive outlook for HealthEquity. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100